ILMN logo

ILMN
Illumina Inc

12,761
Mkt Cap
$27.97B
Volume
1.91M
52W High
$153.06
52W Low
$68.70
PE Ratio
31.61
ILMN Fundamentals
Price
$141.07
Prev Close
$145.83
Open
$145.25
50D MA
$128.39
Beta
1.23
Avg. Volume
1.5M
EPS (Annual)
-$7.69
P/B
9.06
Rev/Employee
$421,600.77
Loading...
Loading...
News
all
press releases
Cerity Partners LLC Increases Stock Position in Illumina, Inc. $ILMN
Cerity Partners LLC boosted its position in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 23.0% during the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·8h ago
News Placeholder
More News
News Placeholder
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?
Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·2d ago
News Placeholder
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zacks·2d ago
News Placeholder
REGN vs. ILMN: Which Stock Is the Better Value Option?
REGN vs. ILMN: Which Stock Is the Better Value Option?
Zacks·4d ago
News Placeholder
TEM's Stable Solvency and Financial Strength Are Gaining Attention
Tempus AI posts a strong Q3 2025 balance sheet with $760M cash, no current debt, and positive adjusted EBITDA, boosting flexibility and solvency.
Zacks·4d ago
News Placeholder
Perhaps We Should Actually Be Focusing On Fixing America
Perhaps We Should Actually Be Focusing On Fixing America Authored by Michael Snyder via TheMostImportantNews.com, After years of heading in the wrong direction, nobody can deny that the United States...
Zero Hedge·5d ago
News Placeholder
REGN vs. ILMN: Which Stock Should Value Investors Buy Now?
REGN vs. ILMN: Which Stock Is the Better Value Option?
Zacks·5d ago
News Placeholder
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis PR Newswire...
PR Newswire·5d ago
News Placeholder
Three Genomics Stocks Worth Tracking This Year
Genomics advances are reshaping drug discovery, with Pacific Biosciences of California emerging as a key player in next-gen sequencing.
Zacks·5d ago
News Placeholder
Illumina, Inc. (NASDAQ:ILMN) Given Consensus Rating of "Hold" by Brokerages
Shares of Illumina, Inc. (NASDAQ:ILMN - Get Free Report) have earned an average recommendation of "Hold" from the twenty-one brokerages that are covering the company, Marketbeat Ratings reports. Two...
MarketBeat·6d ago
<
1
2
...
>

Latest ILMN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.